Submitted by Anonymous (not verified) on 9 June 2026 - 8:30
Agenda - Challenges in drug development, regulation and clinical practice in immune thrombocytopenia
Source:
Agenda - Challenges in drug development, regulation and clinical practice in immune thrombocytopenia